EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ginkgetin effectively mitigates collagen and AA ‐induced platelet activation via PLCγ2 but not cyclic nucleotide‐dependent pathway in human

Chih-Wei Hsia iD, Lan-Hsin Shu, Ai-Wei Lee, Oanh-Thi Tran, Chih-Hao Yang, Ting-Lin Yen, Wei-Chieh Huang, Chih-Hsuan Hsia, Thanasekaran Jayakumar, Kuan-Rau Chiou, Joen-Rong Sheu iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Chih-Wei Hsia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Nucleotides, Cyclic, Phospholipases, Biflavonoids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taipei Medical University-Shuang Ho Hospital, Collaborative Research Project of College of Medicine, Taipei Medical University, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelets assume a pivotal role in the cardiovascular diseases (CVDs). Thus, targeting platelet activation is imperative for mitigating CVDs. Ginkgetin (GK), from Ginkgo biloba L, renowned for its anticancer and neuroprotective properties, remains unexplored concerning its impact on platelet activation, particularly in humans. In this investigation, we delved into the intricate mechanisms through which GK influences human platelets. At low concentrations (0.5–1 μM), GK exhibited robust inhibition of collagen and arachidonic acid (AA)‐induced platelet aggregation. Intriguingly, thrombin and U46619 remained impervious to GK's influence. GK's modulatory effect extended to ATP release, P‐selectin expression, intracellular calcium ([Ca 2+ ]i) levels and thromboxane A 2 formation. It significantly curtailed the activation of various signaling cascades, encompassing phospholipase Cγ2 (PLCγ2)/protein kinase C (PKC), phosphoinositide 3‐kinase/Akt/glycogen synthase kinase‐3β and mitogen‐activated protein kinases. GK's antiplatelet effect was not reversed by SQ22536 (an adenylate cyclase inhibitor) or ODQ (a guanylate cyclase inhibitor), and GK had no effect on the phosphorylation of vasodilator‐stimulated phosphoprotein Ser157 or Ser239 . Moreover, neither cyclic AMP nor cyclic GMP levels were significantly increased after GK treatment. In mouse studies, GK notably extended occlusion time in mesenteric vessels, while sparing bleeding time. In conclusion, GK's profound impact on platelet activation, achieved through inhibiting PLCγ2–PKC cascade, culminates in the suppression of downstream signaling and, ultimately, the inhibition of platelet aggregation. These findings underscore the promising therapeutic potential of GK in the CVDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nucleotides, CyclicPhospholipasesBiflavonoidsHumansAnimalsMicePhospholipase C gammaArachidonic AcidPhosphatidylinositol 3-KinasesPlatelet Aggregation InhibitorsPlatelet ActivationBlood PlateletsPlatelet AggregationProtein Kinase CPhosphorylationCollagen

Stichwörter der Autor:innen

MAPKPI3K/AktPLCγ2ginkgetinhuman plateletsvascular thrombosis

Substanzen

Nucleotides, CyclicPhospholipase C gammaginkgetinArachidonic AcidPhospholipasesPhosphatidylinositol 3-KinasesPlatelet Aggregation InhibitorsProtein Kinase CCollagenBiflavonoids

Autor:innen und Institutionen

  • Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan.
  • Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Department of Anatomy and Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Department of Medical Research, Cathay General Hospital, Taipei, Taiwan.

ORCID-Profile: Chih-Wei Hsia, Joen-Rong Sheu

Förderung

  • Taipei Medical University-Shuang Ho Hospital
  • Collaborative Research Project of College of Medicine, Taipei Medical University
  • National Science and Technology Council
  • Taipei Medical University

Zitieren

APA

Hsia, C. W., Shu, L. H., Lee, A. W., Tran, O. T., Yang, C. H., Yen, T. L., Huang, W. C., Hsia, C. H., Jayakumar, T., Chiou, K. R., & Sheu, J. R. (2024). Ginkgetin effectively mitigates collagen and AA ‐induced platelet activation via PLCγ2 but not cyclic nucleotide‐dependent pathway in human. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18139

Vancouver

Hsia CW, Shu LH, Lee AW, Tran OT, Yang CH, Yen TL, et al. Ginkgetin effectively mitigates collagen and AA ‐induced platelet activation via PLCγ2 but not cyclic nucleotide‐dependent pathway in human. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18139

BibTeX
@article{Hsia2024,
  author = {Hsia, Chih-Wei and Shu, Lan-Hsin and Lee, Ai-Wei and Tran, Oanh-Thi and Yang, Chih-Hao and Yen, Ting-Lin and Huang, Wei-Chieh and Hsia, Chih-Hsuan and Jayakumar, Thanasekaran and Chiou, Kuan-Rau and Sheu, Joen-Rong},
  title = {Ginkgetin effectively mitigates collagen and AA ‐induced platelet activation via PLCγ2 but not cyclic nucleotide‐dependent pathway in human},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18139}
}
Kostenlos starten →